Stryker (SYK) Income from Continuing Operations (2009 - 2026)
Stryker (SYK) reported Income from Continuing Operations of 745000000.0 for Q1 2026, up 13.91% year-over-year from 654000000.0 in Q1 2025, and down 12.25% quarter-over-quarter from 849000000.0 in Q4 2025.
Stryker (SYK) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Income from Continuing Operations data on file, last reported at 745000000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 745000000.0, up 13.91% year-over-year; the trailing twelve-month figure through Mar 2026 was 3337000000.0 (up 16.72% YoY), and the FY2025 annual result was 3246000000.0, up 8.45% from the prior year.
- Income from Continuing Operations fell to 745000000.0 in Q1 2026 per SYK's latest filing, from 849000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1143000000.0 in Q4 2023 and troughed at 323000000.0 in Q1 2022.
- A 5-year average of 735705882.35 and a median of 745000000.0 in 2026 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations soared 103.02% in 2023, then plunged 52.23% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 563000000.0 in 2022, then soared by 103.02% to 1143000000.0 in 2023, then sank by 52.23% to 546000000.0 in 2024, then surged by 55.49% to 849000000.0 in 2025, then fell by 12.25% to 745000000.0 in 2026.
- Business Quant data shows SYK's Income from Continuing Operations at 745000000.0 in Q1 2026, 849000000.0 in Q4 2025, and 859000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 745.00 Mn |
| Dec 31, 2025 | 849.00 Mn |
| Sep 30, 2025 | 859.00 Mn |
| Jun 30, 2025 | 884.00 Mn |
| Mar 31, 2025 | 654.00 Mn |
| Dec 31, 2024 | 546.00 Mn |
| Sep 30, 2024 | 834.00 Mn |
| Jun 30, 2024 | 825.00 Mn |
| Mar 31, 2024 | 788.00 Mn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 692.00 Mn |
| Jun 30, 2023 | 738.00 Mn |
| Mar 31, 2023 | 592.00 Mn |
| Dec 31, 2022 | 563.00 Mn |
| Sep 30, 2022 | 816.00 Mn |
| Jun 30, 2022 | 656.00 Mn |
| Mar 31, 2022 | 323.00 Mn |
| Dec 31, 2021 | 662.00 Mn |
| Sep 30, 2021 | 438.00 Mn |
| Jun 30, 2021 | 592.00 Mn |